Your browser doesn't support javascript.
loading
Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors.
Bang, Chul Hwan; Oh, Hyun Ju; Kim, Yeong Ho; Jung, Jin-Hyung; Lee, Ji Hyun; Park, Young Min; Han, Ju Hee.
Affiliation
  • Bang CH; Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Oh HJ; Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim YH; Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Jung JH; Department of Biostatistics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Lee JH; Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Park YM; Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Han JH; Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. alwaysmine8@gmail.com.
Acta Derm Venereol ; 104: adv34206, 2024 Sep 09.
Article in En | MEDLINE | ID: mdl-39248291

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Uveitis / Severity of Illness Index / Ustekinumab Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Acta Derm Venereol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Uveitis / Severity of Illness Index / Ustekinumab Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Acta Derm Venereol Year: 2024 Document type: Article